Dr. Phuong-Thu Thi Pham, MD

Dr. Pham practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Pham's NPI, 1699795856, was assigned on July 20, 2006. Dr. Pham graduated from Universidad del Noreste in 1987. Dr. Pham holds California license A66828.

Dr. Pham's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Pham's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Pham to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pham practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Pham's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Pham is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Pham's licenses on file in 5 states: California, District of Columbia, Maine, Virginia and Maryland.

CMS data shows 1,161 Medicare services from Dr. Pham across 5 procedure codes in 2024, for 333 Medicare patients. Medicare paid $104,589 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 333 Medicare patients who saw Dr. Pham in 2024. The largest group is under 65, with 201 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 62% are also on Medicaid. Their average risk score is 6.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pham's median patient age at 55, with 41% women.

In 2024, Dr. Pham wrote 773 Medicare Part D claims for 210 patients. 89% of them were for generic drugs. CMS names the drug for 570 of them, across 19 drugs with 11 or more claims each, at $48,747 in total drug cost. In 2023, CMS named 567 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Pham for performance year 2024, reported as part of a group. Dr. Pham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pham as offering telehealth.

Dmand AI links 2 papers to Dr. Pham.

Dmand AI links Dr. Pham to 1 clinical trial.

CMS Open Payments shows 12 general payments to Dr. Pham from 4 drug and device companies from 2017 to 2023. Consulting fees make up the largest share, 83% of the total. Merck Sharp & Dohme Corporation paid the most, $6,694.

Dmand AI lists 1 award for Dr. Pham, most recently CMS Stage 1 EHR in 2013.

Dr. Pham graduated from Universidad del Noreste in 1987.

Dr. Pham is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.